Return-path: <response@response.hansonwade.com>
Envelope-to: amber@transocean.com
Delivery-date: Fri, 15 Jul 2016 06:33:24 -0700
Received: from e220.en25.com ([209.167.231.220]:38714)
	by vps.transocean.com with esmtps (TLSv1:DHE-RSA-AES256-SHA:256)
	(Exim 4.87)
	(envelope-from <response@response.hansonwade.com>)
	id 1bO3F0-0002om-Ta
	for amber@transocean.com; Fri, 15 Jul 2016 06:33:24 -0700
Received: from [10.4.1.245] ([10.4.1.245:62276] helo=P01SNJ017)
	by msm-mta06-tor6 (envelope-from <response@response.hansonwade.com>)
	(ecelerity 3.6.9.48312 r(Core:3.6.9.0)) with ESMTP
	id C1/D2-21124-4F5E8875; Fri, 15 Jul 2016 09:32:36 -0400
Message-ID: <0fab9ce3f7c54865933251dd71ce7d78@2622>
X-Binding: 2622
X-elqSiteID: 2622
X-elqPod: 0x04D4AA276AEFAC548AF4C2541180280C6E4E16410A533B620AAC2EC8FC2601D8
List-Unsubscribe: <http://s2622.t.en25.com/e/u?s=2622&elq=0fab9ce3-f7c5-4865-9332-51dd71ce7d78>
MIME-Version: 1.0
From: "Farrah Ali" <info@hansonwade.com>
To: amber@transocean.com
Reply-To: "Farrah Ali" <info@hansonwade.com>
Date: 15 Jul 2016 09:32:36 -0400
Subject: Today
Content-Type: multipart/alternative;
 boundary=--boundary_2597308_c64b051e-06b5-4ac5-a13a-7b50f9256675
X-Spam-Status: No, score=3.5
X-Spam-Score: 35
X-Spam-Bar: +++
X-Ham-Report: Spam detection software, running on the system "vps.transocean.com",
 has NOT identified this incoming email as spam.  The original
 message has been attached to this so you can view it or label
 similar future email.  If you have any questions, see
 root\@localhost for details.
 
 Content preview:  Hi Alison, Quick reminder that today (July 15) is your final
    opportunity to save up to $500 <http://www.advancedpharma-analytics.com/register/?utm_campaign=APA-6503-INT-EM17-Final%20EBFriday%20reminder&utm_medium=email&utm_source=Eloqua&elqTrackId=56B0A8C841110C40EBB391C1D4DB49F7&elq=0fab9ce3f7c54865933251dd71ce7d78&elqaid=12746&elqat=1&elqCampaignId=11143>
    for the 4th Annual Advanced Pharma Analytics Summit. [...] 
 
 Content analysis details:   (3.5 points, 5.0 required)
 
  pts rule name              description
 ---- ---------------------- --------------------------------------------------
  0.5 URIBL_GOLD             Contains an URL listed in the URIBL GOLDlist
                             [URIs: en25.com]
  1.0 URIBL_GREY             Contains an URL listed in the URIBL greylist
                             [URIs: en25.com]
 -0.0 RCVD_IN_DNSWL_NONE     RBL: Sender listed at http://www.dnswl.org/, no
                             trust
                             [209.167.231.220 listed in list.dnswl.org]
 -0.0 RCVD_IN_MSPIKE_H3      RBL: Good reputation (+3)
                             [209.167.231.220 listed in wl.mailspike.net]
 -0.0 SPF_PASS               SPF: sender matches SPF record
  0.8 BAYES_50               BODY: Bayes spam probability is 40 to 60%
                             [score: 0.4361]
  0.0 HTML_MESSAGE           BODY: HTML included in message
  1.0 HTML_FONT_FACE_BAD     BODY: HTML font face is not a word
 -0.0 RCVD_IN_MSPIKE_WL      Mailspike good senders
  0.2 KAM_LOTSOFHASH         Emails with lots of hash-like gibberish
X-Spam-Flag: NO


----boundary_2597308_c64b051e-06b5-4ac5-a13a-7b50f9256675
Content-Type: text/plain; charset=utf-8
Content-Transfer-Encoding: base64
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----boundary_2597308_c64b051e-06b5-4ac5-a13a-7b50f9256675
Content-Type: text/html; charset=utf-8
Content-Transfer-Encoding: 7bit

<!DOCTYPE html>
<html>
<head>
<!-- StartSystemHeader --><style>body{   } a img{border: none;}.ReadMsgBody { width: 100%;}.ExternalClass {width: 100%;}</style><!-- EndSystemheader --></head>
<body style=""><table align="left" width="7" height="3">
<tbody>
<tr>
<td align="centre"><br></td></tr></tbody></table><br>
 <table width="100%" border="0" cellspacing="0" cellpadding="0" class="email-body-wrapper"><tr><td align="center" height="0"></td></tr><tr><td>
<table cellspacing="0" cellpadding="0" border="0" bordercollapse="collapse" width="600" align="left" id="sc3364" style="table-layout: auto; empty-cells: show"><tr><td valign="top" align="left" rowspan="1" colspan="2" width="597" id="view0" style="color: #000000; font-family: Arial; font-size: 12px; line-height: 18px; letter-spacing: 0px; word-wrap: break-word">
<div id="sc5053" class="sc-view hidden-border inline-styled-view editor-outline" style="left: 0px; width: 597px; top: 0px; color: #000000; font-family: Arial; font-size: 12px; line-height: 18px; letter-spacing: 0px; word-wrap: break-word"><div class="co-border-style" style="">

<table width="597" height="100%" cellspacing="0" cellpadding="0" border="0" bordercollapse="collapse" class="co-style-table" style="color: #000000; font-family: Arial; font-size: 12px; line-height: 18px; letter-spacing: 0px; word-wrap: break-word; margin-top: 0px; margin-left: 0px; margin-right: 0px; margin-bottom: 0px"><tr><td valign="top" class="valign-able"><span class="remove-absolute"><div><span style="letter-spacing:0px;">Hi Alison</span>,</div><div><div><br></div><div>Quick reminder that <b>today
 (July 15) </b>is&nbsp;your final opportunity to&nbsp;<b><a href="http://www.advancedpharma-analytics.com/register/?utm_campaign=APA-6503-INT-EM17-Final%20EBFriday%20reminder&utm_medium=email&utm_source=Eloqua&elqTrackId=56B0A8C841110C40EBB391C1D4DB49F7&elq=0fab9ce3f7c54865933251dd71ce7d78&elqaid=12746&elqat=1&elqCampaignId=11143" data-targettype="webpage">save up to $500</a></b>&nbsp;for the <i>4th Annual Advanced Pharma Analytics Summit</i>.
</div><div><br></div><div>Learn
 from the latest case studies from the likes of <b>Genentech</b>,<b> FDA</b>, <b>Pfizer</b>, <b>EMD Serono</b> and many more who will demonstrate value and tangible ROI derived from effective data sourcing, standardization, integration, infrastructure, real-world evidence and advanced analytics.</div><div><br></div><div><b>
<a href="http://www.advancedpharma-analytics.com/about/agenda/?utm_campaign=APA-6503-INT-EM17-Final%20EBFriday%20reminder&utm_medium=email&utm_source=Eloqua&elqTrackId=51E853B918ABC1C026D095711844B07E&elq=0fab9ce3f7c54865933251dd71ce7d78&elqaid=12746&elqat=1&elqCampaignId=11143" data-targettype="webpage">View agenda</a></b></div><div><br></div><div><b>
<a href="http://www.advancedpharma-analytics.com/register/?utm_campaign=APA-6503-INT-EM17-Final%20EBFriday%20reminder&utm_medium=email&utm_source=Eloqua&elqTrackId=7B86A1C0138D63FD60A816B4BEC3EAE6&elq=0fab9ce3f7c54865933251dd71ce7d78&elqaid=12746&elqat=1&elqCampaignId=11143" data-targettype="webpage">Register online now</a></b> to receive the discounted rate.</div><div><br></div><div>Warm regards,</div><div>Farrah</div></div><div><br></div><div><b>Farrah Ali Ph.D</b></div><div><b>Senior
 Program Director,</b></div><div><b>Hanson
 Wade</b></div></span></td></tr></table></div></div></td><td align="left" valign="top" width="3" id="empty2" style="font-size: 1px">&nbsp;</td></tr><tr><td align="left" valign="top" width="210" height="19" id="empty3" style="font-size: 1px">&nbsp;</td><td align="left" valign="top" width="387" height="19" id="empty4" style="font-size: 1px">&nbsp;</td><td align="left" valign="top" width="3" id="empty5" style="font-size: 1px">&nbsp;</td></tr><tr>
<td valign="top" align="left" rowspan="1" colspan="1" width="214" id="view6" style=""><div id="sc5058" class="sc-view" style="left: -4px; width: 214px; top: 361px; height: 61px"><div class="co-border-style" style="border-width: 2px; border-style: none">
<table width="214" height="100%" cellspacing="0" cellpadding="0" border="0" bordercollapse="collapse" class="co-style-table" style="margin-top: 0px; margin-left: 0px; margin-right: 0px; margin-bottom: 0px"><tr><td valign="top" class="valign-able">
<a href="http://www.advancedpharma-analytics.com/?utm_campaign=APA-6503-INT-EM17-Final%20EBFriday%20reminder&utm_medium=email&utm_source=Eloqua&elqTrackId=FBD4B78D9E47F2A3A40E0D089CF64C40&elq=0fab9ce3f7c54865933251dd71ce7d78&elqaid=12746&elqat=1&elqCampaignId=11143" title="">
<img elqhref="http://www.advancedpharma-analytics.com/?elqTrackId=FBD4B78D9E47F2A3A40E0D089CF64C40" elqtitle="" data-targettype="webpage" width="214" height="61" src="http://img.en25.com/EloquaImages/clients/HansonWadeLtd/%7b75e21d60-70f8-40d7-a4fa-69e2a965d8a7%7d_7920_Advanced_Pharma_Analytics_US_2016_logo_v2.jpg" title="" alt="" id="sc5060" class="sc-view sc-image-view editor-outline sc-regular-size" style="display: block; cursor: pointer"></a></td></tr></table></div></div></td>
<td align="left" valign="top" width="387" id="empty7" style="font-size: 1px">&nbsp;</td><td align="left" valign="top" width="3" id="empty8" style="font-size: 1px">
&nbsp;</td></tr><tr><td align="left" valign="top" width="210" height="78" id="empty9" style="font-size: 1px">&nbsp;</td><td align="left" valign="top" width="387" id="empty10" style="font-size: 1px">&nbsp;</td><td align="left" valign="top" width="3" id="empty11" style="font-size: 1px">&nbsp;</td></tr></table></td></tr><tr>
<td align="center" height="0"></td></tr></table> 
<font style="font-family: Arial; font-size: 10px;" face="">If you no longer wish to receive updates about this meeting <a title="Stop receiving emails about this meeting" href="http://s2622.t.en25.com/e/cu?s=2622&elqc=420&elq=0fab9ce3f7c54865933251dd71ce7d78">click here</a></font><br><font style="font-family: Arial; font-size: 10px;" face="">To
 unsubscribe from all further email communication from Hanson Wade <a title="Opt out of all Hanson Wade email communication" href="http://s2622.t.en25.com/e/u?s=2622&elq=0fab9ce3f7c54865933251dd71ce7d78">click here</a>. </font><br><font style="font-family: Arial; font-size: 10px;" face="">This email was sent to you at: </font><font style="font-family: Arial; font-size: 10px;" face="">amber@transocean.com</font><br><font style="font-family: Arial; font-size: 10px;" face="">
<a title="Hanson Wade" href="http://www.hansonwade.com/?utm_campaign=APA-6503-INT-EM17-Final%20EBFriday%20reminder&utm_medium=email&utm_source=Eloqua&elq=0fab9ce3f7c54865933251dd71ce7d78&elqCampaignId=11143">Hanson Wade</a> respects your <a title="Privacy Policy" href="http://hansonwade.com/privacy?utm_campaign=APA-6503-INT-EM17-Final%20EBFriday%20reminder&utm_medium=email&utm_source=Eloqua&elq=0fab9ce3f7c54865933251dd71ce7d78&elqCampaignId=11143">privacy</a></font><br>
<font style="font-family: Arial; font-size: 10px;">&copy; 2012, Hanson Wade, 52 Grosvenor Gardens, London, SW1W 0AU</font>

<img src='http://s2622.t.en25.com/e/FooterImages/FooterImage1?elq=0fab9ce3f7c54865933251dd71ce7d78&siteid=2622' alt="" border=0 width=1px height=1px></body></html>
----boundary_2597308_c64b051e-06b5-4ac5-a13a-7b50f9256675--


